Is There a Role for Adjuvant Therapy in Patients with Large Juvenile Nasopharyngeal Angiofibromas?
Adjuvant therapy may have a limited role in select patients with advanced JNAs to achieve acceptable outcomes while minimizing serious morbidity and mortality.
Source: ENTtoday - TRIO Best Practices - Category: ENT & OMF Authors: Charles A. Riley, MD, and David A. Gudis, MD Tags: Pediatric Pediatric Otolaryngology Practice Focus TRIO Best Practices adjuvant therapy Juvenile nasopharyngeal angiofibromas Source Type: research
More News: ENT & OMF | Pediatrics